Form 4: Gossamer Bio Executive Caryn Peterson Acquires 440,000 Stock Options
SEC Form 4 Filing
Caryn Peterson, EVP of Regulatory Affairs at Gossamer Bio, Inc., was granted 440,000 stock options on March 4, 2025.
Summary
- Caryn Peterson, EVP of Regulatory Affairs at Gossamer Bio, Inc., filed a Form 4 on March 6, 2025, reporting a transaction.
- On March 4, 2025, Peterson acquired 440,000 stock options with an exercise price of $1.13.
- The options vest over time, with 25% vesting on March 4, 2026, and the remainder vesting monthly thereafter, contingent upon continuous service.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing related to executive compensation. It doesn't inherently convey strong positive or negative sentiment, but the granting of stock options can be seen as a moderately positive sign of alignment between management and shareholders.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future performance.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign, aligning executive interests with company performance.
- Employees may see the grant as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of stock option grant. |
| 03/04/2026 | Date when 25% of the stock options vest. |
| 03/06/2025 | Date of Form 4 filing. |
| 03/03/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.